+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vivus - logo

VIVUS is a biopharmaceutical company that develops and commercializes therapies to address unmet medical needs in the United States and the European Union. The company’s lead product Qsymia is a combination appetite suppressant/stimulant and seizure medication indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in overweight and obese adults. VIVUS was founded in 1991 and is headquartered in Campbell, California.

Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • February 2017
  • 91 Pages
From
From
From
Global Anti-obesity Drugs Market 2018-2022 - Product Thumbnail Image

Global Anti-obesity Drugs Market 2018-2022

  • Report
  • November 2018
  • 99 Pages
From
From
From
Antiobesity Drugs Global Market Report 2020 - Product Thumbnail Image

Antiobesity Drugs Global Market Report 2020

  • Report
  • November 2019
  • 200 Pages
From
Qsymia 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Qsymia 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 26 Pages
From
Obesity - Pipeline Review, H1 2020 - Product Thumbnail Image

Obesity - Pipeline Review, H1 2020

  • Drug Pipelines
  • May 2020
  • 592 Pages
From
Obesity - Pipeline Review, H2 2019 - Product Thumbnail Image

Obesity - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 567 Pages
From
From
Obesity: Competitive Landscape to 2026 - Product Thumbnail Image

Obesity: Competitive Landscape to 2026

  • Report
  • October 2018
  • 50 Pages
From
PDE Inhibitors Market, 2016-2026 - Product Thumbnail Image

PDE Inhibitors Market, 2016-2026

  • Report
  • October 2016
  • 223 Pages
From
From
Type 2 Diabetes - Pipeline Review, H1 2020 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Review, H1 2020

  • Drug Pipelines
  • May 2020
  • 1220 Pages
From
QSYMIA Drug Profile, 2019 - Product Thumbnail Image

QSYMIA Drug Profile, 2019

  • Report
  • August 2020
  • 56 Pages
From
Loading Indicator
adroll